Bridget Kennedy
Primary Care · Newtown, PANPI 1518685395
Payments from drug & device makers
Across 73 payments — averaging $22.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- EMD Serono, Inc.$373
- AbbVie$263
- AstraZeneca$153
- Impel Pharmaceuticals Inc.$116
- UCB, Inc.$100
- SK Life Science, Inc.$63
- plus $587 from 18 others
What the payments were for
- Food & beverage$1,656100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| EMD Serono, Inc. | 20 | $373 |
| AbbVie | 14 | $263 |
| AstraZeneca | 6 | $153 |
| Impel Pharmaceuticals Inc. | 2 | $116 |
| UCB, Inc. | 5 | $100 |
| SK Life Science, Inc. | 3 | $63 |
| Argenx US, Inc. | 2 | $62 |
| Genentech USA, Inc. | 2 | $53 |
| Novartis | 3 | $51 |
| Harmony Biosciences LLC | 1 | $46 |
| MDD US Operations, LLC | 1 | $41 |
| Biogen | 2 | $41 |
| Amgen | 1 | $37 |
| Lundbeck LLC | 1 | $33 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $27 |
| Lilly USA, LLC | 1 | $26 |
| Boston Scientific | 1 | $25 |
| Scilex Pharmaceuticals Inc. | 1 | $24 |
| Impel Pharmaceuticals LLC | 1 | $24 |
| Bristol Myers Squibb | 1 | $23 |
| Pfizer | 1 | $22 |
| Pacira Pharmaceuticals Incorporated | 1 | $19 |
| Teva Pharmaceuticals USA, Inc. | 1 | $18 |
| Acorda Therapeutics, Inc | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Trudhesa$101
How this compares
$1,656 in reported general payments places this provider in the 75th percentile of 300 primary care providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Levetiracetam | 23 | $1,050 |
| Duloxetine Hcl | 12 | $817 |
| Carbidopa-LevodopaCarbidopa/Levodopa | 14 | $673 |
| Donepezil Hcl | 30 | $602 |
| ClopidogrelClopidogrel Bisulfate | 16 | $423 |
| Atorvastatin Calcium | 41 | $353 |
| Gabapentin | 16 | $341 |
| Memantine Hcl | 20 | $246 |
| Rosuvastatin Calcium | 21 | $219 |
| Pregabalin | 13 | $184 |
Paid to pharmacies, not to this prescriber.
Other primary care in Newtown
- Kersten ReiderMount Penn$121K
- Teresa GiamboyPhiladelphia$21K
- Nicole IlgenfritzBethel Park$18K
- Galyna VorokhibPhiladelphia$12K
- Melissa BeansWarrington$12K
- Mollie McGuireJohnstown$11K
- Andrea MauriceNew Cumberland$11K
- Kendell SoglieroSmithfield$9K
- Minjung RegerDoylestown$9K
- Mackenzie HouserMedia$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.